FDA says Ip­ca Labs failed to ad­dress qual­i­ty is­sues with bad API batch­es

Ip­ca Lab­o­ra­to­ries, an In­dia-based mak­er of ac­tive phar­ma­ceu­ti­cal in­gre­di­ents, was cit­ed for sev­er­al qual­i­ty and test­ing is­sues dur­ing a re­cent FDA in­spec­tion.

The FDA …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER